{"filing":{"accession_number":"0001437749-26-023639","cik":"0001716621","ticker":"VTAK","company_name":"Catheter Precision, Inc.","form":"8-K","filing_date":"2026-07-15","report_date":null,"primary_document":"vtak20260714_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1716621/000143774926023639/vtak20260714_8k.htm"},"events":[{"id":18213,"run_id":16364,"accession_number":"0001437749-26-023639","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Cathay Precision closed an unregistered private placement of 3,470 shares of Series C-3 Convertible Preferred Stock for $3.47 million pursuant to Securities Purchase Agreements dated February 6 and March 9, 2026. The preferred stock is convertible into common stock at $0.632 per share, creating significant dilution to existing common shareholders upon conversion.","company_name":"Catheter Precision, Inc.","ticker":"VTAK","filing_date":"2026-07-15","form":"8-K","submitted_at":null,"items":[{"id":16954,"accession_number":"0001437749-26-023639","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the closing of an unregistered sale of 3,470 shares of Series C-3 Convertible Preferred Stock for $3.47 million, issued pursuant to Securities Purchase Agreements dated February 6 and March 9, 2026. The preferred stock is convertible into common stock at $0.632 per share, creating significant dilution potential. This is a classic private placement of convertible securities by a small-cap company (VTAK) raising capital, fitting the dilutive_issuance category under Item 3.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T21:15:43.946024+00:00","company_name":"","ticker":null,"filing_date":""},{"id":16955,"accession_number":"0001437749-26-023639","item_number":"3.03","item_title":"Material Modification to Rights of Security Holders.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The disclosure describes issuance of Series C-3 Preferred Stock that will result in dilution of existing Common Stock holders upon conversion. The filing explicitly states \"conversion of the Series C-3 Preferred Stock into Common Stock will result in dilution of the existing holders of Common Stock,\" which is a hallmark of dilutive issuance. The Certificate of Designation filed as Exhibit 3.1 establishes the terms of this senior security with conversion rights, typical of preferred stock financings that materially affect shareholder equity structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T21:15:43.946024+00:00","company_name":"","ticker":null,"filing_date":""},{"id":16956,"accession_number":"0001437749-26-023639","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.85,"reasoning":"The filing discloses a routine amendment to the Company's articles of incorporation—specifically, the designation of 3,470 shares of Series C-3 Convertible Preferred Stock via a Certificate of Designation filed with Delaware. This is a standard corporate governance action that does not itself constitute a material event to investors absent context showing the preferred stock is being issued in connection with a financing, acquisition, or other material transaction. The disclosure is administrative in nature and does not affect the total mix of information available about the registrant's financial condition or operations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T21:15:43.946024+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16954,"accession_number":"0001437749-26-023639","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the closing of an unregistered sale of 3,470 shares of Series C-3 Convertible Preferred Stock for $3.47 million, issued pursuant to Securities Purchase Agreements dated February 6 and March 9, 2026. The preferred stock is convertible into common stock at $0.632 per share, creating significant dilution potential. This is a classic private placement of convertible securities by a small-cap company (VTAK) raising capital, fitting the dilutive_issuance category under Item 3.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T21:15:43.946024+00:00","company_name":"Catheter Precision, Inc.","ticker":"VTAK","filing_date":"2026-07-15"},{"id":16955,"accession_number":"0001437749-26-023639","item_number":"3.03","item_title":"Material Modification to Rights of Security Holders.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The disclosure describes issuance of Series C-3 Preferred Stock that will result in dilution of existing Common Stock holders upon conversion. The filing explicitly states \"conversion of the Series C-3 Preferred Stock into Common Stock will result in dilution of the existing holders of Common Stock,\" which is a hallmark of dilutive issuance. The Certificate of Designation filed as Exhibit 3.1 establishes the terms of this senior security with conversion rights, typical of preferred stock financings that materially affect shareholder equity structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T21:15:43.946024+00:00","company_name":"Catheter Precision, Inc.","ticker":"VTAK","filing_date":"2026-07-15"},{"id":16956,"accession_number":"0001437749-26-023639","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.85,"reasoning":"The filing discloses a routine amendment to the Company's articles of incorporation—specifically, the designation of 3,470 shares of Series C-3 Convertible Preferred Stock via a Certificate of Designation filed with Delaware. This is a standard corporate governance action that does not itself constitute a material event to investors absent context showing the preferred stock is being issued in connection with a financing, acquisition, or other material transaction. The disclosure is administrative in nature and does not affect the total mix of information available about the registrant's financial condition or operations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T21:15:43.946024+00:00","company_name":"Catheter Precision, Inc.","ticker":"VTAK","filing_date":"2026-07-15"}]}